文献速递脊柱关节炎

体重指数与中轴型脊柱关节炎疾病活动度的系统综述与荟萃分析

Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis.
PubMed 文献 · RMD Open · 2020-01-01

结果显示,超重/肥胖者相比正常BMI者BASDAI和ASDAS的合并标准化均数差分别为0.38(95%CI 0.21–0.55)和0.40(95%CI 0.27–0.54),提示高BMI与更高疾病活动度相关。

要点

  • 超重/肥胖axSpA患者BASDAI合并SMD为0.38(95%CI 0.21–0.55),提示疾病活动度更高。
  • 超重/肥胖axSpA患者ASDAS合并SMD为0.40(95%CI 0.27–0.54),与BASDAI结果一致。
  • 亚组分析结果稳健,但研究间BASDAI分析异质性较高(I²=75.2%)。

核心结论

  • 在axSpA研究中,超重/肥胖BMI与更高的疾病活动度(BASDAI或ASDAS)存在关联。

研究设计与样本

  • 采用随机效应模型估计合并标准化均数差(SMD)及95%CI。

主要发现

  • 比较肥胖(BMI>30 kg/m²)或超重/肥胖(BMI>25 kg/m²)与正常BMI(18.5–24.9 kg/m²)者,BASDAI合并SMD为0.38(95% CI 0.21–0.55,I²=75.2%)。
  • ASDAS合并SMD为0.40(95% CI 0.27–0.54,I²=0%)。
  • 亚组分析结果稳健。

临床怎么用

  • 临床评估axSpA疾病活动度时,可考虑将BMI作为影响BASDAI/ASDAS评分的因素之一。
  • 对超重/肥胖的axSpA患者,疾病活动度评分可能偏高,需结合整体情况解读。

局限性

  • 研究间BASDAI分析的异质性较高(I²=75.2%)。
  • 原文指出未来需纵向研究评估该关联随时间的变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In axial spondyloarthritis (axSpA), higher body mass index (BMI) is associated with worse outcomes including response to biologics. Further clarity is needed on whether BMI is associated with disease activity overall, independent of treatment response. We performed a systematic review and meta-analysis to assess the association between BMI and disease activity as reported by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) or Ankylosing Spondylitis Disease Activity Score (ASDAS) in axSpA. METHODS: We systematically searched for studies evaluating BMI and disease activity as the exposure and outcome of interest, respectively, in axSpA. Using random effects models, we estimated summary standardised mean differences (SMDs) and 95% CIs of BASDAI or ASDAS, comparing obese (BMI>30 kg/m2) or overweight/obese (BMI>25 kg/m2) individuals to those with normal BMI (18.5-24.9 kg/m2). RESULTS: Twelve studies were included in the meta-analysis. Among all studies reporting the BASDAI at baseline, the pooled SMD of the BASDAI for those with an obese or overweight/obese BMI compared to a normal BMI was 0.38 (95% CI 0.21 to 0.55, I2 =75.2%), indicating a significant association of higher BMI with higher BASDAI score. The pooled SMD of the ASDAS for those with an obese or overweight/obese BMI compared to a normal BMI was 0.40 (95% CI 0.27 to 0.54, I2=0%). Findings were robust across subgroup analyses. CONCLUSION: These results demonstrate an association between an overweight/obese BMI and higher disease activity in studies of axSpA. Future longitudinal studies of BMI and disease activity should assess how this association changes over time.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Liew JW, Huang IJ, Louden DN, et al. Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis. RMD Open. 2020. PMID: 32434828. doi:10.1136/rmdopen-2020-001225

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。